• Michel Vounatsos on his commitment to building a world class research and science-focused organization
  • Biogen discovers, develops, commercializes and manufactures transformative therapies for patients with few or no treatment options
  • We are driving a deeper understanding of disease biology and developing impactful treatments for the millions of people suffering from neurological and neurodegenerative conditions.
  • Inspired impact: Working to solve difficult challenges is the foundation of both our research and our corporate responsibility
Biogen’s new CEO
Introducing Michel Vounatsos
Impact for Patients

We aspire to have the greatest impact on patients of any biotechnology company in the history of our industry.

A Transformative Age of Neurology

As a leading company in the fight against multiple sclerosis, Biogen is applying its expertise to help address some of most challenging and complex diseases of the brain.

Caring Deeply. Changing Lives.™

The same passion that drives our science is reflected in our corporate citizenship, environmental sustainability and commitment to diversity.

Biogen Completes Separation of Global Hemophilia Business, Bioverativ
The new company, known as Bioverativ, is an independent, publicly traded global biotechnology company focused on hemophilia and other rare blood disorders
Click here to find out more
Innovative Therapies

We develop medicines for debilitating medical conditions with the goal of making a meaningful difference in patients’ lives.

Dedicated to new discoveries

Our pipeline is more than a list of medicines in development. It reflects the work we do here every day to break new ground with science that makes a difference in the lives of patients.

Building the next Biogen


As we embark on building the Biogen of the future, we will focus on areas with the potential to have the most impact, developing life-changing treatments for people suffering from devastating conditions.

Review our 2015 performance

Caring deeply about those around us

We understand that what we do matters – to our patients, our employees and the communities in which we live and work.